INTRODUCTION
A l z h e i m e r 's d i s e a s e ( A D ) i s a n i r r e v e r s i b l e degenerative brain disorder that affects memory, intellectual ability, and other cognitive functions.
1 AD is the most common form of dementia and a leading cause of morbidity and mortality globally. The 2015 World Alzheimer Report showed that approximately 47 million people have AD or related dementias worldwide. 2 As populations continue to age, the number of persons living with dementia, including AD, is expected to rise to over 130 million by 2050 -this increase will particularly affect countries with a fastgrowing elderly population. 2 Individuals aged 60 years and above are projected to constitute a fifth of the world population over the next three-four decades, and more than 75% will be living in Asia, Latin America or Africa. 3 Despite the current epidemiology of AD and its economic and public health impacts, the cause of the disease remains unknown.
Several genetic and non-genetic factors have been linked to AD. For instance, genetic factors such as mutations in amyloid precursor protein (APP), for eligible studies was conducted by two reviewers (O.O and O.O). Eligible studies were those that included a representative population of healthy individuals at baseline or persons with AD, cohort or case-control studies that reported the effect of at least one toxic environmental risk factor on AD, and studies that used a standardized definition of AD e.g. based on the National Institute of Neurologic and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA), the Diagnostic and Statistical Manual for Mental Disorders, (DSM III-R, DSM IV, DSM V), the International Classification of Diseases, 9 th and 10 th revisions (ICD-9, ICD-10), or histopathologic criteria. Studies in which the diagnostic criteria for AD were not clearly stated were excluded. Where two or more publications reported on the same cohort/study population, the most recent publication was selected. All disagreements regarding the eligibility of any of the studies were resolved by discussion among the reviewers.
Two reviewers (O.O and B.A) extracted relevant data from all eligible articles into a data extraction form designed by the authors using Microsoft Excel. The following study variables were extracted; last name of first author, publication year, study design, study setting/country; characteristics of study population including age at baseline, gender, and follow-up period where applicable; environmental exposure(s) examined and assessment method; method for AD diagnosis and diagnostic criteria; confounding variables; study result and conclusion. The extracted data were quality-checked by M.A (an expert environmental and occupational health physician) and G.T.G (an expert geriatric psychiatrist).
To evaluate the quality of all eligible studies, we adapted a quality assessment tool developed jointly by National Heart, Lung, and Blood Institute and Research Triangle Institute International. 14 The tool included items for assessing potential flaws in study methodology or implementation, including sources of bias, confounding, study power, and other factors. Quality reviewers (O.O and O.O) selected "yes" or "no" in response to each item on the tool. The total score for each study was based on the percentage of "Yes". A study was classified as "high quality" if the total quality score was ≥80%; "moderate quality" if total score was between 80% and 59%; and "low quality" if it scored below 60%.
RESULTS

Study Selection
Our PubMed search yielded 7,434 articles. Of these, 7,091 were excluded following title and abstract screening. A second review of the remaining 343 articles led to the exclusion of an additional 233 articles. After full-text screening, 27 articles, in presenilin 1, or presenilin 2 genes have been found to cause early-onset/familial AD while lateonset AD, the more common type, is reported to result from interaction between risk genes (e.g. apolipoprotein E-4) and environmental factors. 4 Furthermore, recent studies suggest epigenetic modifications in the etiology of late-onset AD; that is, modification in chemical compounds that regulate gene expression. 5, 6 Because genetic factors are largely non-modifiable, public health efforts aimed at reducing the global burden of AD are focusing on environmental risk factors. There is especially a growing interest in the role of toxic environmental factors (defined in this article as hazardous substances such as solvents, pesticides, toxic metals, electromagnetic fields (EMF), and air pollutants) in the development of AD. [7] [8] [9] [10] [11] [12] [13] While some studies suggest a link between toxic environmental factors and AD, others have been inconclusive. [7] [8] [9] For instance, in a 2007 review assessing the quality of studies on risk factors for AD, significant associations were found between work-related pesticide exposure and AD in high quality studies while less consistent associations were reported for other toxic exposures (such as EMF, solvents, lead, and aluminum). 7 In a 2015 metaanalysis, no significant associations were found for occupational exposures to pesticide, solvent, aluminium, and low frequency EMF. 8 Scientific studies suggesting a possible link between air pollution and neurodegenerative diseases (e.g., AD) are also emerging. 9 Previous reviews of the environmental risk factors for AD have been conducted; however, most either focused on occupational exposure to a single risk factor or used a non-systematic methodology. [10] [11] [12] [13] To fill the aforementioned gap, we conducted this systematic review with the aim to assess the evidence on the link between AD and exposure to a variety of toxic environmental risk factors beyond the work environment. Given that public health actions taken at the global and national levels have been effective in reducing or eliminating human exposure to several hazardous agents, examining the evidence linking toxic environmental agents to the development of AD is imperative.
METHODS
We searched PubMed for articles on AD that were published in English. No time-period restriction was used so that all published articles related to AD could be retrieved. The search was conducted on 31 January 2016 and updated on 24 October 2016 using the following keywords: "Alzheimer", "Alzheimer's", "Alzheimer's disease", "risk factors", and "risk factor". The MeSH heading "Alzheimer's disease" was also used. Screening occupational exposure to EMF levels ≥0.2 microtesla (µT) (adjusted relative risk (RR): 2.3; 95% CI: 1.0-5.1). 41 Another cohort study conducted in Sweden found the same risk increase for AD mortality among men occupationally exposed to EMF ≥0.5 µT (adjusted RR: 2.3; 95% CI: 1.6-3.3). 39 Results from a populationbased study of dementia in Swedish Twins found a significant risk of AD among manual worker (adjusted OR: 2.09; 95% CI: 1.04-4.19). 16 In an analysis of data from three independent clinical series and controls in Finland and the U.S., primary lifetime occupational exposure to medium (2-10 mG) to high (>10 mG), compared to low EMF exposure, was associated with sporadic AD (adjusted odds ratio (OR): 2.9; 95% CI: 1.6-5.4). 34 This finding was replicated in a subsequent case-control study involving individuals from an AD Treatment Center in the U.S. (adjusted OR: 3.93; 95% CI:1.5-10.6). 35 In both studies, 34, 35 dressmaker, tailor, and seamstress were among the occupations considered to have medium to high EMF exposure. In an analysis of deaths among men who resided in one of 25 U.S. states, a stronger association was found between AD and specific occupations such as electricians (adjusted OR: 1.4; 95% CI: 1.1-1.7) and power plant operators (adjusted OR: 2.6; 95% CI: 1.3-5.1) when compared to all electrical occupations combined (adjusted OR: 1.2; 95% CI:1.0-1.4). 33 A separate analysis of death certificate data from 22 states in the U.S. showed that 60 hertz EMF exhibited a small but significant exposure-response for AD (Mortality OR: 1.12; 95% CI: 1.05-1.20). 31 In a population based casecontrol study conducted in Turkey, occupational EMF exposure and use of electricity for residential heating were found to be significant risk factors for AD (OR: 4.02; 95% CI: 1.02-15.78 and OR: 2.77; 95% CI:1.12-6.85 respectively). 28 Three 17,31,42 out of six studies found statistically significant associations between pesticide exposure and AD. In one of the studies, occupational exposure to fumigants and defoliants was found to increase the risk of AD significantly (RR: 4.35; 95% CI: 1.05-17.90).
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Three 18,29,37 out of nine studies found aluminum exposure to be a significant risk factor for AD. Two 26, 31 out of four studies on solvent exposure reported a link with AD. We identified two recent studies on air pollution and AD risk. 20, 21 21 addition to two articles identified from our reference list search, were included in the final analysis (n=29) (Figure 1 ).
Study Characteristics
The main characteristics of the 29 eligible studies are shown in Table 1 . Seven of the 29 selected studies were published within the last decade. [15] [16] [17] [18] [19] [20] [21] We identified 18 case-control 16, [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] and 11 cohort studies. 15, [17] [18] [19] [20] [21] [39] [40] [41] [42] [43] The sample sizes varied across studies; ranging from 134 in a case-control study 24 to approximately 4.8 million in a cohort study of economically active individuals in the Swedish 1980 census. 39 The age of the study participants ranged from 16 years 39 to greater than 75 years. 25, 41 Thirteen of 29 studies were conducted in North America, 11 studies were conducted in Europe, three in Asia, and one in Australia. One study, a case-control analysis, examined patients from two locations in Finland and an Alzheimer's Disease Research Center in the United States (U.S.). 34 Most of the studies involved both male and female participant. Four studies 22, 30, 33, 43 examined males only and one study investigated the risk of AD in women who took part in the Epidemiology of Osteoporosis (EPIDOS) study. 25 The most common toxic environmental risk factors examined by the studies included EMF (n=12), aluminum (n=9), pesticides (n=6), and solvents (n=4). Other risk factors examined include air pollutants (n=2), lead (n=2), mercury (n=1), and atomic bomb radiation (n=1). For most of the studies, exposure to the examined risk factors occurred within the work environment. To diagnose AD, 20 of the 29 selected studies used the NINCDS-ADRDA criteria while in seven studies, diagnosis of AD was based on the ICD criteria. In one study conducted in Canada, AD cases and controls were defined based on strict neuropathologic criteria. 29 
Quality Assessment
The percentage agreement between raters was 95%. Disagreements were resolved by discussion among reviewers. Overall, the quality scores of the included studies ranged from 58.33% to 88.33%. Six 18-21,39,43 out of 11 cohort studies and only two 26, 30 out of 18 casecontrol studies were considered high quality. The individual item, assessment responses, and quality scores can be found in Tables 2 and 3 .
Key Findings
Twelve of the 29 included articles assessed the effect of exposure to EMF. Of the 12 studies, eight 16, 28, 31, [33] [34] [35] 39, 41 found statistically significant associations between EMF exposure and AD. One of the studies, a communitybased cohort study conducted in Sweden, found an increased risk of AD in men following lifetime No statistically significant associations w e r e f o u n d b e t w e e n a n y o f t h e occupational exposures and AD Comparing all AD cases (A1 + A2) with all non-AD controls (C1 + C2), and using the Aluminum level of public drinking water at last residence before death, the estimated RR associated with Aluminum ≥100 µg/L was 1.7 (95% CI: 1.2-2.5). Aluminum exposure from a 10-year weighted residential history resulted in estimates of relative risk of 2.5 or greater Noonan et al. 2002 , Casecontrol, U.S. 30 1,556 cases 60 years or more and 1,556 controls formed from among recorded deaths of males in the state of Colorado for the years 1987 through 1996
Occupational EMF exposure assessed using three methods: electrical versus nonelectrical occupations, three-tiered grouping of potential magnetic field exposure based on a combination of job title and industry, and categories of exposure based on the means of the magnetic fields estimated from a JEM Death certificate, ICD-9
Age, race, and occupational grouping No consistent associations with magnetic fields were observed for AD 43 Men at five large U.S. electric utility companies who worked for at least 6 months between 1950 and 1986. Death certificates for 20,068 deceased men were obtained. AD was indicated in 56 deaths. Median age at the time of death was 78 years Occupational EMF exposure assessed as duration of work in exposed jobs and through an index of cumulative exposure based on magnetic field measurements Death certificate, ICD-9
A g e , c a l e n d a r y e a r , social class, work status, polychlorinated biphenyl exposure and solvent exposure AD was weakly associated with duration of employment in jobs associated with elevated magnetic field exposure The adjusted OR for all cases/controls was 2.9 (95% CI: 1.6-5.4). Adjusted OR was 3.9 (95% CI: 1.7-8.6) for women and 1.9 (95% CI: 0.8-5.0) for men Sobel et al. 1996 , Casecontrol, U.S. 35 326 male and female cases from ADDTC at RLAMC who were at least age 65 at the time of their first examination at RLAMC compared with 152 controls who had cognitive impairment/ dementia other than vascular dementia Occupational EMF exposure measured per previous study (Sobel et al. 1995 15 2,286 male and female subjects (members of the Adult Health Study cohort) who were non-demented and aged ≥60 years at baseline examination and had been exposed at ≥13 years of age to a relatively low dose (≤4 Gy). Mean study period: 5.9 years Exposure to atomic bomb radiation (individual brain dose based on RERF's Dosimetry System 2002). Radiation dose was estimated as weighted sums of gamma ray and neutron components in Gy, and divided into three categories: <5 mGy (nonexposed), 5-499 mGy, and ≥500 mGy Clinical evaluation, NINCDS-ADRDA for probable AD and possible AD A g e , s e x , e d u c a t i o n , BMI, smoking, drinking, menopausal age, history of hypertension, diabetes, and stroke After adjustment for potential risk factors, radiation exposure did not affect the incidence rate of AD AD, Alzheimer's disease; ELF-MF, extremely low-frequency magnetic fields; EMF, electromagnetic fields; OR, odds ratio; CI, confidence interval; HR, hazard ratio; RR, relative risk; JEM, job-exposure matrix; IH, industrial hygienist; NIOSH, National Institute for Occupational Safety and Health; ISCO, International Standard Classification of Occupations; CBTB, Canadian Brain Tissue Bank; DWSP, Drinking Water Surveillance Program; COPD, Chronic Obstructive Pulmonary Disease; BMI, Body Mass Index; WHR, waist-hip ratio; A1 + A2, decedents with a clinical history of dementia and the histopathologic findings suggestive of AD and decedents with clinical dementia and AD pathology coexisting with some other neuropathologic process; C1 + C2, decedents with no histopathology plus a second group composed of decedents with Huntington's disease, schizophrenia, multiple sclerosis, multiple infarcts, Jakob-Creutzfeldt disease, and other neurodegenerative diseases for which aluminum has never been implicated; PMR, proportionate mortality ratio; PAQUID, Personnes aˆge´es Quid; USC ADRC, University of Southern California site of the Alzheimer's Disease Research Center of Los Angeles and Orange Counties; ADDTC at RLAMC, Alzheimer Disease Treatment and Diagnostic Center, Rancho Los Amigos Medical Center; RERF, Radiation Effects Research Foundation. 39 Hayden et al. 2010 17 Johansen C. 2000 40 Jung et al. 2015 21 Oudin et al. 2016 20 Qiu et al. 2004 41 Rondeau et al. 2009 18 Savitz et al. 1998 43 Sorahan et al. 2014 19 Tyas et al. 31 Salib and Hillier 1996 32 Savitz et al. 1998 33 Shalat et al.
1988 22 Sobel et al.
1995 34 Sobel et al. 1996 35 *CSHA 1994 38 Wang et al. found slightly higher AD risks in EMF-exposed subjects, the reported strengths of association are generally in keeping with two recent meta-analyses conducted in 2008 and 2013. 44, 45 In the 2008 metaanalysis, pooled estimates from nine case-control and five cohort studies showed a stronger association between EMF exposure and AD compared with the meta-analysis conducted in 2013; pooled estimates in the 2013 study were from 13 case-control studies and six cohort studies.
Regarding exposure to metals, aluminum was the most commonly studied. Aluminum is a widely known neurotoxin and has been shown to have toxic effects on the central nervous system; however, its role in the etiology of AD remains unclear. Results from three studies showed that high intake of aluminum from drinking water and frequent use of aluminum containing products such as antiperspirants was associated with an increased risk of AD. 18, 29, 37 Overall, the low number of studies on other metals (such as lead and mercury) makes definitive conclusions on their impact on AD risk difficult. Exposure to pesticides was found to be a significant risk factor for AD. In one study, the authors found an increased risk of AD that was more evident in persons with occupational exposure to organophosphate pesticides. 17 Another study found a risk of AD that was over four times higher among subjects with occupational exposure to two types of pesticidesfumigants and defoliants. 42 Occupational exposure to other types of pesticides (such as herbicides and insecticides) was not found to increase AD risk. In one of the studies on solvent exposure, an increasing risk of AD was found with increasing number of years N o s i g n i f i c a n t a s s o c i a t i o n s w e re f o u n d f o r occupational exposures to lead 22, 27 and mercury. 27 Results from a study involving individual from the Adult Health Study Cohort in Hiroshima did not provide any support for a possible relationship between radiation exposure and AD. 15 4. DISCUSSION
Summary of Findings
Our review identified a broad group of toxic environmental risk factors for AD reported in 29 studies. Unlike previous reviews and meta-analyses, which either focused on one environmental factor or occupational exposure(s), [44] [45] [46] our review explored exposure to several risk factors in and outside the work environment. Of all the risk factors identified, EMF was the most commonly studied. EMF has been reported to affect several processes within the body including calcium homeostasis and melatonin production in the brain but the exact mechanism via which it causes AD is still not known. [47] [48] [49] In our review, eight out of 12 studies found EMF to be a significant risk factor for developing AD. The earliest studies investigating the link between EMF and AD were conducted in 1995 and 1996 by Sobel et al. 34, 35 Compared to individuals with none to low EMF exposure, the authors found the odds of occupational exposure to medium to high EMF to be two to three times higher among subjects with AD. Similar magnitude of association were reported in subsequent studies. 28, 31, 33, 39, 41, 43 Although some of the studies included in this review Records excluded on second appraisal based on: study design (n=77), study population (n=103), environmental exposure (n=53)
Full-text articles excluded based on: study design (n =1), study population (n=1), environmental exposure (n=72), diagnostic criteria for AD (n=2), duplicate cohort (n=7) Reference list search: 2 DNA sequence. 57 Epigenetic modifications especially those related to DNA methylation may explain the link between environmental risk factors and late-onset AD. Several AD-related genes contain methylated CpG sites (sites where cytosine lies next to guanine in the DNA sequence) in their promoter regions. 58 Low levels of methylation at these regions have been implicated in the etiology of AD. 59 For instance, demethylation in the promoter region of the APP gene was found to be associated with amyloid-β deposition in the aged brain. 60 Two post-mortem studies found a significant decrease in DNA methylation in the hippocampus and entorhinal cortex of post-mortem samples with AD. 61, 62 Furthermore, recent reviews of the scientific literature have found a correlation between toxic environmental factors and decreased levels of DNA methylation. 63, 64 Studies have also suggested that early exposure to metals such as lead could result in epigenetic modifications of AD-related genes and subsequent dysregulated expression later in life. 65 Despite the emergence of new information on the possible link between specific groups of toxic exposures and AD, research on toxic environmental agents in general and their role in the etiology of AD appears to have declined over the years. In our review for example, only seven out of 29 selected studies were published within the last decade. The level of evidence observed in some of the selected studies appear to be high and should not be ignored. Rather, necessary precautions should be taken in settings where the risk of exposure to implicated toxic environmental agents is high. There is no doubt that more studies are needed to validate the evidence seen.
Limitations in the Original Studies
We identified key methodological issues that may have resulted in inconsistencies in findings across studies. These issues need to be addressed in future studies to facilitate interpretation of study results and more importantly, to improve the validity of study results.
We found that measurement of exposure levels was a challenge in most studies. The methods used to assess the different exposure levels were fairly inconsistent across studies. For some studies, the degree of exposure was based on assumptions made by the investigators or an expert and in others, the methods used to determine the level of exposure was not clearly stated. For instance, in Sobel et al. (1995) , probable exposure to ELF-MF for each occupation was blindly assessed by a certified industrial hygienist and by direct measurement of magnetic fields while in the population-based study of Swedish Twins, occupational exposure to ELF-MF was determined from a job exposure matrix which was based on workday measurements of magnetic fields obtained from a specific population. 16 of exposure to solvents. 26 In another study, small but significant linear associations were observed for solvents and AD. 31 Evidence is now emerging of a possible link between air pollution, second-hand smoke and neurodegenerative conditions, including AD. 46 In various studies, air pollutants have been demonstrated to trigger chronic oxidative stress, a mechanism involved in the pathogenesis of AD. 50 In a study conducted using autopsy brain samples from Mexican subjects, exposure to severe air pollution was found to be associated with brain inflammation and accumulation of amyloid-β 42, known causes of neuronal dysfunction that precede the appearance of neuritic plaques and neurofibrillary tangles which are neuropathological hallmarks of AD. 51 Similarly, Maher et al found magnetite, an airborne nanoparticle, in fresh frozen brain tissues of 38 individuals who lived in two major cities in the United Kingdom and Mexico. 9 Magnetite exposure has been linked to oxidative damage in brain cells especially in the presence of amyloid-β protein. 9, 52 We identified two eligible studies on air pollution and AD. Results from one of the studies, a population-based study which used data from 70 Taiwan Environmental Protection Agency (EPA) monitoring station on Taiwan's main island, suggest that long-term exposure to ozone and PM 2.5 above the current U.S. EPA standards are associated with increased risk of AD. 21 The second study, involving participants from a major city in Sweden, found non-significant associations between traffic air pollution (NOx levels) and AD. 20 Regarding second-hand smoke (SHS) and AD, studies have suggested a cardiovascular disease-related mechanism similar to that seen with smoking. 53, 54 We identified a large population-based cross-sectional study of never-smoked people in China. The result showed a significant risk for AD following exposure to SHS at home and in the workplace. 55 In a USbased study examining the association between selfreported lifetime household SHS exposure and risk of incident dementia, the authors found that subjects with over 25 years of SHS exposure and greater than 25% carotid artery stenosis had a three-fold increase in dementia risk compared with subjects with no to low (i.e., 0-15 years) SHS exposure. Most (64%) of the subjects with dementia had AD. Moderate (16-25 years) and high (>25 years) SHS exposure levels, however, were not independently associated with dementia risk. 56 These findings, if substantiated, have significant public health implications because of the endemicity of SHS as well as the close relationship between air pollution and climate change.
Evidence is also emerging on the role of epigenetic mechanisms in the development of neurodegenerative diseases. Epigenetics involve heritable changes in gene expression that occur without changes in the approach is often difficult given the inter-individual variability in the toxicokinetics of the different toxic environmental agents and the challenges in obtaining and processing tissue samples especially from a large group of participants. Given that case-control studies are prone to recall bias and do not usually allow the determination of exposure prior to the outcome of interest, we recommend that researchers conduct cohort studies that involve large numbers of individuals followed for adequate periods of time.
Limitations of Review
Since the literature search was conducted in one electronic database, our search may have missed publications that could significantly impact our findings. Having this in mind, we used a search strategy that will allow us retrieve as many relevant articles as possible from the database. We also supplemented our search with a manual search of the reference lists of eligible articles. Although our original aim was to combine the results from eligible studies in a meta-analysis, this method would not have been appropriate given the variation in the assessment of exposure as described above.
CONCLUSION
Our review highlights important evidence on the role of toxic environmental factors in the development of AD. We identified 29 eligible studies which focused on exposure to several toxic environmental factors mostly in the work setting. Of all the risk factors identified, the evidence was mostly significant for exposure to EMF. In light of this evidence, it is important to further explore the relationship between EMF exposure and AD given that humans are exposed to some amounts of EMF on a daily basis. Significant associations were also found for aluminum, pesticides, and solvents exposure. Overall, more work is needed to substantiate existing evidence on the possible role of toxic environmental risk factors in the etiology of AD. Research efforts should focus on designing high quality longitudinal studies that will facilitate appropriate definition and accurate measurement of exposures, ensure adequate follow-up given the long latency period between environmental exposures and development of AD, and limit potential sources of bias at study design level or during analysis of collected data. More epigenetic studies are also needed to determine the pathophysiologic mechanisms by which environmental factors cause AD.
Since some study results were based largely on data from specific job classes, exposure levels regarded as medium or high in one study may not be comparable to the same exposure levels in others. Inconsistencies in measurement of exposure pose a significant problem when synthesizing information from different epidemiological studies. In a recent meta-analysis of modifiable risk factors for AD, the lack of evidence for significant associations between AD and four occupational exposures including low frequency EMF, aluminum, pesticide, and solvents was attributed to differences in the measurement approaches used for the exposures. 8 Another review assessing the quality of epidemiological studies on occupational risk factors for AD noted that the lack of a valid assessment of exposure in some of the studies may have impacted evidence conclusion. 7 In most cases, it was difficult to determine the true impact of the environmental exposure of interest since data on the intensity exposure was scarce. The source of information was another issue that may have underestimated the risks seen in some of the studies. Recall bias is often a problem in case-control studies more so if the information was obtained from the subjects. The use of proxy informants as was the case in some studies is also likely to lead to information bias as it is often difficult to obtain a comprehensive report on exposures from such informants. 17 In one study that did not find consistent associations between occupational exposure to magnetic fields and AD, a major study limitation was the use of death certificates to obtain both exposure and disease data. 30 The use of death certificate information in epidemiological studies often creates errors especially when incomplete as is the case in many parts of the world. There is also the issue of inaccuracies with recording the underlying cause of death particularly for chronic disorders such as AD. In a recent retrospective cohort study, only 53.6% of decedents who were diagnosed clinically with dementia were certified with dementia as a cause of death at the beginning of the observation period. 66 Definition and classification of exposure was also a challenge. In one study 24 exposures were classified in the broad category of "pesticides", "insecticides" or "herbicides" while in another study, specific types of pesticides including organophosphates, organochlorines, carbamates, and methyl bromides were examined. 17 Based on these observations, we recommend that future research efforts focus on improving and standardizing methods used to assess exposure to toxic environmental agents. An example is the use of well-designed questionnaires to capture indicators that are proxies of actual exposures in different settings. A more objective approach is to directly measure the levels of toxic agents or their metabolites in human biological specimens. However, this
